NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM). Such investors are advised to contact Danielle Peyton at […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ZoomInfo Technologies Inc. (“ZoomInfo” or the “Company”) (NASDAQ: ZI). Such investors are advised to contact Danielle Peyton at […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG). Such investors are advised to contact Danielle Peyton at [email protected] or […]
